ArriVent BioPharma OverviewArriVent BioPharma Other Income Expense Net
Other Income/Expense Net for AVBP.
Quarterly Other Income/Expense
$2.79M
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$8.35M
↓ 20.92% YoY
Trailing 12 months ending Mar 31, 2026